A brain-tumor neural circuit controls breast cancer progression in mice
Journal of Clinical Investigation · 15.12.2023 · 133 (24)
DOI: 10.1172/jci167725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.12.2023. Verfasst von Si-Yi Xiong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Breast and Thyroid Surgery, Southwest Hospital. Hauptthemen laut MEDLINE: Corticotropin-Releasing Hormone, Neoplasms. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Chongqing Talent Plan.
Abstract (Originalsprache)
Tumor burden, considered a common chronic stressor, can cause widespread anxiety. Evidence suggests that cancer-induced anxiety can promote tumor progression, but the underlying neural mechanism remains unclear. Here, we used neuroscience and cancer tools to investigate how the brain contributes to tumor progression via nerve-tumor crosstalk in a mouse model of breast cancer. We show that tumor-bearing mice exhibited significant anxiety-like behaviors and that corticotropin-releasing hormone (CRH) neurons in the central medial amygdala (CeM) were activated. Moreover, we detected newly formed sympathetic nerves in tumors, which established a polysynaptic connection to the brain. Pharmacogenetic or optogenetic inhibition of CeMCRH neurons and the CeMCRH→lateral paragigantocellular nucleus (LPGi) circuit significantly alleviated anxiety-like behaviors and slowed tumor growth. Conversely, artificial activation of CeMCRH neurons and the CeMCRH→LPGi circuit increased anxiety and tumor growth. Importantly, we found alprazolam, an antianxiety drug, to be a promising agent for slowing tumor progression. Furthermore, we show that manipulation of the CeMCRH→LPGi circuit directly regulated the activity of the intratumoral sympathetic nerves and peripheral nerve-derived norepinephrine, which affected tumor progression by modulating antitumor immunity. Together, these findings reveal a brain-tumor neural circuit that contributes to breast cancer progression and provide therapeutic insights for breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Breast and Thyroid Surgery, Southwest Hospital.
- Department of Neurobiology, Chongqing Key Laboratory of Neurobiology, College of Basic Medical Sciences.
- Department of Medical Genetics, College of Basic Medical Sciences.
- Experimental Center of Basic Medicine, Chongqing Key Laboratory of Neurobiology, College of Basic Medical Sciences.
- Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences.
- Department of Clinical Biochemistry, Faculty of Pharmacy and Laboratory Medicine, and.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Chongqing Talent Plan
- Army Medical University
Zitieren
APA
Xiong, S. Y., Wen, H. Z., Dai, L. M., Lou, Y. X., Wang, Z. Q., Yi, Y. L., Yan, X. J., Wu, Y. R., Sun, W., Chen, P. H., Yang, S. Z., Qi, X. W., Zhang, Y., & Wu, G. Y. (2023). A brain-tumor neural circuit controls breast cancer progression in mice. Journal of Clinical Investigation, 133(24). https://doi.org/10.1172/jci167725
Vancouver
Xiong SY, Wen HZ, Dai LM, Lou YX, Wang ZQ, Yi YL, et al. A brain-tumor neural circuit controls breast cancer progression in mice. Journal of Clinical Investigation. 2023;133(24). doi:10.1172/jci167725
BibTeX
@article{Xiong2023,
author = {Xiong, Si-Yi and Wen, Hui-Zhong and Dai, Li-Meng and Lou, Yun-Xiao and Wang, Zhao-Qun and Yi, Yi-Lun and Yan, Xiao-Jing and Wu, Ya-Ran and Sun, Wei and Chen, Peng-Hui and Yang, Si-Zhe and Qi, Xiao-Wei and Zhang, Yi and Wu, Guang-Yan},
title = {A brain-tumor neural circuit controls breast cancer progression in mice},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {133},
number = {24},
doi = {10.1172/jci167725}
}
EUVIMED